Dolby Laboratories (DLB) Stock Price, News & Analysis

Company Overview

Dolby Laboratories, Inc. is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays. The company also offers professional tools and workflows for content creation, mastering and live production, ensuring consistency and fidelity across theatrical, broadcast and on-demand environments.

Founded in 1965 by inventor Ray Dolby in London, Dolby Laboratories established its headquarters in San Francisco to foster close collaboration with the entertainment industry. Over the decades, Dolby has grown to serve customers in more than 50 countries, operating regional offices across North America, Europe and Asia. Since 2013, Kevin Yeaman has served as President and Chief Executive Officer, guiding the company’s expansion into new markets such as immersive audio for virtual reality, live entertainment venues and automotive sound systems. Dolby continues to focus on research and development, holding thousands of patents that underpin its reputation for innovation in audio and imaging technology.

Key Stats

• Today's Range: $67.33 to $68.15
• 50-Day Range: $67.13 to $75.59
• 52-Week Range: $66.96 to $89.66
• Volume: 43,890 shs
• Average Volume: 442,401 shs
• Market Capitalization: $6.47 billion
• P/E Ratio: 24.74
• Dividend Yield: 1.95%
• Price Target: $95.75
• Consensus Rating: Moderate Buy

Dolby Laboratories Stock Analysis - MarketRank™

Dolby Laboratories scored higher than 99% of companies evaluated by MarketBeat, and ranked 7th out of 296 stocks in the consumer discretionary sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Dolby Laboratories has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 3 buy ratings, 3 hold ratings, and no sell ratings.

Upside Potential

Dolby Laboratories has a consensus price target of $95.75, representing about 41.0% upside from its current price of $67.91.

Amount of Analyst Coverage

Dolby Laboratories has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 8.16%

Earnings Growth

Earnings for Dolby Laboratories are expected to grow by 8.16% in the coming year, from $2.94 to $3.18 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Dolby Laboratories is 24.87, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 82.65.

Price to Earnings Ratio vs. Sector

The P/E ratio of Dolby Laboratories is 24.87, which means that it is trading at a more expensive P/E ratio than the Consumer Discretionary sector average P/E ratio of about 18.49.

Price to Book Value per Share Ratio

Dolby Laboratories has a P/B Ratio of 2.61. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

3.44% of the float of Dolby Laboratories has been sold short.

Short Interest Ratio / Days to Cover

Dolby Laboratories has a short interest ratio ("days to cover") of 4.6.

Change versus previous month

Short interest in Dolby Laboratories has recently increased by 8.90%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 4.2 / 5
• Dividend Strength: Strong

Dividend Yield

Dolby Laboratories pays a meaningful dividend of 1.90%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Dolby Laboratories has been increasing its dividend for 10 years.

Dividend Coverage

The dividend payout ratio of Dolby Laboratories is 48.35%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, Dolby Laboratories will have a dividend payout ratio of 41.51% next year. This indicates that Dolby Laboratories will be able to sustain or increase its dividend.

Sustainability and ESG

• Score: 3.5 / 5
• Environmental Score: -0.42

Percentage of Shares Shorted

3.44% of the float of Dolby Laboratories has been sold short.

Short Interest Ratio / Days to Cover

Dolby Laboratories has a short interest ratio ("days to cover") of 4.6.

Change versus previous month

Short interest in Dolby Laboratories has recently increased by 8.90%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 3.0 / 5
• News Sentiment: 1.31

News Sentiment

Dolby Laboratories has a news sentiment score of 1.31. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.72 average news sentiment score of Consumer Discretionary companies.

News Coverage This Week

MarketBeat has tracked 8 news articles for Dolby Laboratories this week, compared to 8 articles on an average week.

Search Interest

Only 1 people have searched for DLB on MarketBeat in the last 30 days. This is a decrease of -89% compared to the previous 30 days.

MarketBeat Follows

4 people have added Dolby Laboratories to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Dolby Laboratories insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $5,845,440.00 in company stock.

Percentage Held by Insiders

38.39% of the stock of Dolby Laboratories is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

58.56% of the stock of Dolby Laboratories is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

DLB Stock Analysis - Frequently Asked Questions

How have DLB shares performed this year?

Dolby Laboratories' stock was trading at $78.10 at the beginning of the year. Since then, DLB stock has decreased by 13.1% and is now trading at $67.9050.

How were Dolby Laboratories' earnings last quarter?

Dolby Laboratories (NYSE:DLB) announced its quarterly earnings results on Thursday, July, 31st. The electronics maker reported $0.78 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.72 by $0.06. The company's revenue was up 9.2% on a year-over-year basis.
Read the conference call transcript.

How will Dolby Laboratories' stock buyback program work?

Dolby Laboratories' board authorized a share repurchase plan on Wednesday, August 7th 2024, which allows the company to repurchase $350,000,000 in shares, according to EventVestor. This means that the company could repurchase up to 5% of its shares through open market purchases. Shares buyback plans are generally a sign that the company's leadership believes its shares are undervalued.

Does Dolby Laboratories have any subsidiaries?

Dolby Laboratories subsidiaries include these companies: Voxeet, Doremi Labs, Step Labs, Coding Technologies, Dolby International AB, and Dolby Laboratories Licensing Corporation.

Who are Dolby Laboratories' major shareholders?

Dolby Laboratories' top institutional shareholders include Boston Trust Walden Corp (1.14%), Pacer Advisors Inc. (0.46%), Ninety One UK Ltd (0.43%) and Robeco Institutional Asset Management B.V. (0.17%). Insiders that own company stock include John D Couling, Kevin J Yeaman, Shriram Revankar, Mark Andrew Sherman, Todd Pendleton, Simon Segars, Ryan Nicholson, Anjali Sud and Emily Rollins.
View institutional ownership trends.

How do I buy shares of Dolby Laboratories?

Shares of DLB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Dolby Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Dolby Laboratories investors own include Humana (HUM), American Water Works (AWK), Waste Connections (WCN), Voyager Therapeutics (VYGR), The RMR Group (RMR), DiamondRock Hospitality (DRH) and AUO (AUOTY).

Company Calendar

• Last Earnings: 7/31/2025
• Record date for 8/20 Dividend: 8/12/2025
• Ex-Dividend for 8/20 Dividend: 8/12/2025
• Dividend Payable: 8/20/2025
• Today: 10/24/2025
• Next Earnings (Estimated): 11/18/2025
• Fiscal Year End: 9/30/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Consumer Discretionary
• Industry: AUDIO/VIDEO PRD
• Sub-Industry: Electronic Components
• Current Symbol: NYSE:DLB
• CIK: 1308547
• Web: www.dolby.com
• Phone: (415) 558-0200
• Fax: 415-645-4000
• Employees: 2,080
• Year Founded: 1965

Price Target and Rating

• Average Price Target for Dolby Laboratories: $95.75
• High Price Target: $114.00
• Low Price Target: $74.00
• Potential Upside/Downside: +41.8%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 6 Analysts

Profitability

• EPS (Trailing Twelve Months): $2.73
• Trailing P/E Ratio: 24.74
• Forward P/E Ratio: 22.97
• P/E Growth: N/A
• Net Income: $261.83 million
• Net Margins: 19.62%
• Pretax Margin: 23.87%
• Return on Equity: 11.52%
• Return on Assets: 9.26%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 3.44
• Quick Ratio: 3.36

Sales & Book Value

• Annual Sales: $1.35 billion
• Price / Sales: 4.81
• Cash Flow: $3.78 per share
• Price / Cash Flow: 17.88
• Book Value: $26.06 per share
• Price / Book: 2.59

Miscellaneous

• Outstanding Shares: 95,844,000
• Free Float: 59,049,000
• Market Cap: $6.47 billion
• Optionable: Optionable
• Beta: 0.92